These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 14442589)

  • 1. [Determinations of erythrocyte survival by the Cr-51 method in hemolytic anemia during therapy].
    SCHEITLIN W; FRICK P
    Schweiz Med Wochenschr; 1959 Dec; 89():1328-31. PubMed ID: 14442589
    [No Abstract]   [Full Text] [Related]  

  • 2. [Life span of erythrocytes and sites of their destruction in hemolytic anemia].
    Sakhibov IaD; Aripov AIa
    Probl Gematol Pereliv Krovi; 1967 Dec; 12(12):16-20. PubMed ID: 5618029
    [No Abstract]   [Full Text] [Related]  

  • 3. The L-asparaginase effect on the erythrocyte survival time in patients with acquired hemolytic anemia of the IgG and IgA type.
    Wazewska-Czyzewska M; Astaldi G; Lisiewicz J
    Boll Ist Sieroter Milan; 1971; 50(5):429-35. PubMed ID: 5163530
    [No Abstract]   [Full Text] [Related]  

  • 4. [HALF-LIFE OF RED BLOOD CELLS IN HEMOLYTIC SYNDROMES STUDIED WITH RADIOACTIVE CHROMIUM (CR 51)].
    MEZA-ARRAU C; CARRASCOREYES V
    Sangre (Barc); 1965; 10():155-62. PubMed ID: 14316022
    [No Abstract]   [Full Text] [Related]  

  • 5. Erythrocyte survival studies in childhood. III. Unusual familial hemolytic anemias associated with intrinsic erythrocyte abnormality.
    KAPLAN E; ZUELZER WW
    J Lab Clin Med; 1950 Oct; 36(4):524-30. PubMed ID: 14779067
    [No Abstract]   [Full Text] [Related]  

  • 6. A novel method for calculating mean erythrocyte age using erythrocyte creatine.
    Kameyama M; Koga M; Okumiya T
    Aging (Albany NY); 2020 May; 12(9):8702-8709. PubMed ID: 32392179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary excretion of 51 Cr from labeled erythrocytes. An index of erythrocyte survival.
    Shih SC; Tauxe WN; Fairbanks VF; Taswell HF
    JAMA; 1972 May; 220(6):814-7. PubMed ID: 5067347
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hemolytic anemia in the aged-etiology and management].
    Imamura T; Koyama T
    Nihon Ronen Igakkai Zasshi; 1982 May; 19(3):264-8. PubMed ID: 7120686
    [No Abstract]   [Full Text] [Related]  

  • 9. [A case of hemolytic anemia with stomatocytosis].
    Turpin F; Lortholary P; Lejeune F; Claer R
    Nouv Rev Fr Hematol; 1971; 11(4):585-94. PubMed ID: 4257433
    [No Abstract]   [Full Text] [Related]  

  • 10. [Erythrocyte life span and surface activity measurement with Cr 51 in hemolytic anemias: before and after treatment].
    Gehrmann G; Grobel P
    Nucl Med (Stuttg); 1963; 2():Suppl 1:217-23. PubMed ID: 5900115
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of erythrocyte survival by the determination of glycosylated hemoglobin. Clinical value].
    Rigal D; Monestier M; Baboin-Jaubert M; Chabaud-Sassoulas D; Marseglia GL; Ville D; Meyer F; Jouvenceaux A
    Presse Med; 1985 Mar; 14(9):521-3. PubMed ID: 3157163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RELATION OF ALTERED PLASTICITY OF THE ERYTHROCYTES TO THEIR SHORTENED LIFE SPAN.
    TEITEL P
    Sangre (Barc); 1964; 41():421-6. PubMed ID: 14248829
    [No Abstract]   [Full Text] [Related]  

  • 13. [Etiology of hemolytic anemia].
    Schmidt PM
    Schweiz Med Wochenschr; 1981 Aug; 111(33):1201-7. PubMed ID: 7280629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of Cr 51 in the assessment of the role of the spleen in red cell destruction.
    Hughes-Jones NC
    Nucl Med (Stuttg); 1963; 2():Suppl 1:185-93. PubMed ID: 5900111
    [No Abstract]   [Full Text] [Related]  

  • 15. [Exceptional changes in the erythroblast nuclei during an acute dyserythropoietic hemolytic anemia].
    Bohinjec J
    Wien Med Wochenschr; 1968 Apr; 118(14):301-3. PubMed ID: 5678072
    [No Abstract]   [Full Text] [Related]  

  • 16. [Erythrocyte metabolism in acquired hemolytic and refractory anemias].
    Zdebska E; Maj S; Daszyński J
    Acta Haematol Pol; 1971; 2(1):27-34. PubMed ID: 4145003
    [No Abstract]   [Full Text] [Related]  

  • 17. [Chromium 51 for the determination of erythrocyte survival time after heart surgery with the use of the heart-lung machine and in hemolytic anemias].
    FREY KW; SCHMIDT-MENDE M
    Arztl Forsch; 1963 May; 17():258-65. PubMed ID: 13959647
    [No Abstract]   [Full Text] [Related]  

  • 18. [RED BLOOD CELL HALF-LIFE IN HEMOLYTIC SYNDROMES STUDIED WITH RADIOACTIVE CHROMIUM (CR51)].
    MEZA C; CARRASCO V
    Rev Med Chil; 1964 Sep; 92():695-9. PubMed ID: 14242625
    [No Abstract]   [Full Text] [Related]  

  • 19. [Criteria of the biological value of erythrocytes in preserved blood. II. Tests in vivo. Determination of post-transfusion survival of erythrocytes with the method of differential agglutination. Review of the literature].
    Fiala J
    Vnitr Lek; 1969 May; 15(5):489-95. PubMed ID: 4893309
    [No Abstract]   [Full Text] [Related]  

  • 20. Biphasic loss of red cell enzyme activity during in vivo aging.
    Beutler E
    Prog Clin Biol Res; 1985; 195():317-33. PubMed ID: 3903773
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.